Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a biopharma-focused SPAC that filed an 8-K with the SEC on February 10, 2025, under accession number 0001493152-25-005641. The company, which operates in the life sciences and biopharmaceutical sector, represents the post-combination entity following the original blank-check vehicle's de-SPAC transaction. The 8-K filing signals a material corporate event reportable under Exchange Act obligations. Investors and analysts tracking SPAC activity in the healthcare and biopharma space can monitor PWUP alongside hundreds of other active and completed SPAC vehicles. Sign up at SpacDesk for full filing history, status tracking, and sponsor data on PWUP and the broader SPAC market.